{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:33:16Z","timestamp":1793075596644,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16 \/12\/00328"],"award-info":[{"award-number":["CB16 \/12\/00328"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00990"],"award-info":[{"award-number":["PI21\/00990"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jlb.2026.100493","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:08:24Z","timestamp":1788534504000},"page":"100493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating immune profiling reveals immune signatures associated with disease stage and outcome in endometrial cancer"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-2901","authenticated-orcid":false,"given":"Raquel","family":"Pi\u00f1eiro-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-2530","authenticated-orcid":false,"given":"Ana","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-9502","authenticated-orcid":false,"given":"Efigenia","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-0097","authenticated-orcid":false,"given":"Victoria","family":"Sampayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5075-0251","authenticated-orcid":false,"given":"Alicia","family":"Abalo-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0936-6815","authenticated-orcid":false,"given":"Carmela","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-9266","authenticated-orcid":false,"given":"Alexandra","family":"Cortegoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0047-0921","authenticated-orcid":false,"given":"Ra\u00fal","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-3232","authenticated-orcid":false,"given":"Eva","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5030-6687","authenticated-orcid":false,"given":"Gema","family":"Moreno-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9886-6628","authenticated-orcid":false,"given":"Isabel","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7925-4996","authenticated-orcid":false,"given":"Sonia","family":"Blanco-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-7069","authenticated-orcid":false,"given":"Lidia","family":"V\u00e1zquez-Tu\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-5158","authenticated-orcid":false,"given":"Isaura","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-7587","authenticated-orcid":false,"given":"Ester","family":"Munera-Maravilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-174X","authenticated-orcid":false,"given":"Silvia","family":"Calabuig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-6901","authenticated-orcid":false,"given":"Cristina","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-137X","authenticated-orcid":false,"given":"Ana","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1315-655X","authenticated-orcid":false,"given":"Rafael","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-4595","authenticated-orcid":false,"given":"Juan","family":"Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-901X","authenticated-orcid":false,"given":"Juan E.","family":"Vi\u00f1uela-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-7531","authenticated-orcid":false,"given":"Laura","family":"Muinelo-Romay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jlb.2026.100493_bib1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jlb.2026.100493_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jlb.2026.100493_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.jlb.2026.100493_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111448","article-title":"Treatment strategies for advanced endometrial cancer according to molecular classification","volume":"25","author":"Tuninetti","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jlb.2026.100493_bib5","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/2326-6066.CIR-19-0311","article-title":"Tumor immune microenvironment and chemosensitivity signature for predicting response to chemotherapy in gastric cancer","volume":"7","author":"Jiang","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"10.1016\/j.jlb.2026.100493_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","article-title":"Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer","volume":"35","author":"Bogani","year":"2024","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.jlb.2026.100493_bib7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jlb.2026.100493_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","article-title":"Clinical actionability of molecular targets in endometrial cancer","volume":"19","author":"Urick","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jlb.2026.100493_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-024-03158-w","article-title":"Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application","volume":"43","author":"Casas-Arozamena","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.jlb.2026.100493_bib10","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/1078-0432.CCR-24-2105","article-title":"Genomic landscape of ctDNA and real-world outcomes in advanced endometrial cancer","volume":"30","author":"Soberanis Pina","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.jlb.2026.100493_bib11","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-0732-3","article-title":"Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma","volume":"10","author":"Kondratiev","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100493_bib12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41591-020-0892-6","article-title":"Systemic dysfunction and plasticity of the immune macroenvironment in cancer models","volume":"26","author":"Allen","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jlb.2026.100493_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-023-00578-2","article-title":"Defining and using immune archetypes to classify and treat cancer","volume":"23","author":"Combes","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jlb.2026.100493_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.734948","article-title":"Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, or monocyte-to-lymphocyte ratio in endometrial neoplasms: a systematic review and meta-analysis","volume":"12","author":"Leng","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.jlb.2026.100493_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/curroncol32030121","article-title":"CD8+CD28+PD1\u2212 T cells as a prognostic biomarker in endometrial cancer","volume":"32","author":"Nie","year":"2025","journal-title":"Curr Oncol"},{"issue":"8","key":"10.1016\/j.jlb.2026.100493_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00262-019-02355-3","article-title":"Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection","volume":"68","author":"Zhou","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.jlb.2026.100493_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/nm1201-1339","article-title":"Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells","volume":"7","author":"Zou","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jlb.2026.100493_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jlb.2026.100493_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jlb.2026.100493_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.24265\/horizmed.2018.v18n3.11","article-title":"Inmunolog\u00eda del c\u00e1ncer I: bases moleculares y celulares de la respuesta inmune antitumoral","volume":"18","author":"de Le\u00f3n","year":"2018","journal-title":"Horiz Med (Lima)"},{"key":"10.1016\/j.jlb.2026.100493_bib21","article-title":"Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma","volume":"7","author":"Kusano","year":"2017","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.jlb.2026.100493_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/jcm14020401","article-title":"PD-1 and PD-L1 expression in endometrial cancer: a systematic review of the literature","volume":"14","author":"Tommasi","year":"2025","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jlb.2026.100493_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2326-6066.CIR-13-0133","article-title":"PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection","volume":"2","author":"MacFarlane","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jlb.2026.100493_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713132","article-title":"Polyfunctional KLRG-1+CD57+ senescent CD4+ T cells infiltrate tumors and are expanded in peripheral blood from breast cancer patients","volume":"12","author":"Ramello","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jlb.2026.100493_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","article-title":"CD57 in human natural killer cells and T-lymphocytes","volume":"65","author":"Kared","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jlb.2026.100493_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jlb.2026.100493_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10147-008-0789-8","article-title":"Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer","volume":"13","author":"Akagi","year":"2008","journal-title":"Int J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jlb.2026.100493_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of T cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.jlb.2026.100493_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","article-title":"Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine","volume":"21","author":"Kumagai","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.jlb.2026.100493_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s43018-024-00796-z","article-title":"p53 at the crossroads of tumor immunity","volume":"5","author":"Efe","year":"2024","journal-title":"Nat Cancer"},{"issue":"8","key":"10.1016\/j.jlb.2026.100493_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jlb.2026.100493_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jlb.2026.100493_bib33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4161\/onci.20307","article-title":"New insights on the role of CD8(+)CD57(+) T-cells in cancer","volume":"1","author":"Wu","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jlb.2026.100493_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4933-5-6","article-title":"Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people","volume":"5","author":"Koch","year":"2008","journal-title":"Immun Ageing"},{"issue":"4","key":"10.1016\/j.jlb.2026.100493_bib35","article-title":"La mol\u00e9cula CD28 y su funci\u00f3n en la activaci\u00f3n de c\u00e9lulas T","volume":"29","author":"Saavedra-Hern\u00e1ndez","year":"2013","journal-title":"Rev Cubana Hematol Inmunol Hemoter"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:30Z","timestamp":1793073690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950195426000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"alternative-id":["S2950195426000391"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100493","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating immune profiling reveals immune signatures associated with disease stage and outcome in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100493"}}